Who owns Jazz Pharmaceuticals (JAZZ)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Jazz Pharmaceuticals (JAZZ) in their latest 13F filing, with $888.2M between them. Tweedy, Browne team gives it the most weight: 1.12% of the reported portfolio. In their latest reported quarter, Tweedy, Browne team, Josef Lakonishok, Jim Simons (1938–2024) and Ken Griffin and 1 more reduced.
Steve Cohen sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- Josef Lakonishok, $494.5M
- Largest weight
- Tweedy, Browne team, 1.12%of their portfolio
- Combined value
- $888.2M
- Bought last quarter
- 0
- Sold last quarter
- 6
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Tweedy, Browne teamTweedy, Browne Company | 1.12% | $13.7M | 59.28K | ▼ Reduced 1.5% | −872 | Q3 2026 |
| 2 | Josef LakonishokLSV Asset Management | 0.91% | $494.5M | 2.14M | ▼ Reduced 6.1% | −139.24K | Q3 2026 |
| 3 | Jim Simons (1938–2024)Renaissance Technologies | 0.15% | $112M | 483.57K | ▼ Reduced 14% | −78.53K | Q3 2026 |
| 4 | Ken GriffinCitadel Advisors | 0.14% | $242.6M | 1.01M | ▼ Reduced 20% | −252.77K | Q2 2026 |
| 5 | Howard GleicherAristotle Capital Management | 0.06% | $25.4M | 109.78K | ▼ Reduced 1.7% | −1.91K | Q3 2026 |
Sold out last quarter
- Steve Cohenwas $67.8M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 4 | 2.79M | $645.6M | 0 | 4 |
| Q2 2026 | 157 | 5 | 4.02M | $967.7M | 0 | 6 |
| Q1 2026 | 157 | 7 | 6.65M | $1.3B | 4 | 3 |
| Q4 2025 | 157 | 5 | 5.24M | $891.5M | 2 | 3 |
| Q3 2025 | 157 | 4 | 4.2M | $553.5M | 2 | 2 |
| Q2 2025 | 157 | 2 | 2.72M | $288.6M | 2 | 1 |
| Q1 2025 | 156 | 5 | 4.41M | $547.8M | 3 | 2 |
| Q4 2024 | 156 | 4 | 3.92M | $482.9M | 2 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Josef Lakonishok | 2.14M | 2.28M | 2.39M | 2.46M | 2.51M | 2.55M | 2.47M | 2.53M |
| Jim Simons (1938–2024) | 483.57K | 562.07K | 819.37K | 836.77K | 924.87K | — | 1.04M | 1M |
| Howard Gleicher | 109.78K | 111.7K | 130.55K | 158.84K | 158.06K | 165.57K | 158.87K | 195.94K |
| Tweedy, Browne team | 59.28K | 60.15K | 60.21K | — | — | — | — | — |
| Ken Griffin | · | 1.01M | 1.26M | — | — | — | — | — |
| Israel Englander | · | — | 1.26M | 1.2M | — | — | — | — |
| Brandon Haley | · | — | 733.91K | 589.74K | 605.11K | — | 492.03K | — |
| Ray Dalio (founder) | · | — | — | — | — | — | 250.95K | 192.04K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own JAZZ?
In their latest 13F filings: Tweedy, Browne team (1.12% of the portfolio, $13.7M), Josef Lakonishok (0.91% of the portfolio, $494.5M), Jim Simons (1938–2024) (0.15% of the portfolio, $112M), Ken Griffin (0.14% of the portfolio, $242.6M), Howard Gleicher (0.06% of the portfolio, $25.4M).
Who sold JAZZ last quarter?
Reduced: Tweedy, Browne team (1.5% fewer shares), Josef Lakonishok (6.1% fewer shares), Jim Simons (1938–2024) (14% fewer shares), Ken Griffin (20% fewer shares), Howard Gleicher (1.7% fewer shares). Sold out entirely: Steve Cohen (was $67.8M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Jazz Pharmaceuticals (JAZZ)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/JAZZ/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to JAZZ by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.